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Adipose Tissue Derived Mesenchymal Stem Cells Accelerate Healing of CD18-Deficient Chronic
Wounds via the Release of TGF-β1 and Induction of Myofibroblast Differentiation
D Jiang, Y Qi, A Sindrilaru, K Singh, S Vander Beken, A Hainzl, M Wlaschek and K Scharffetter-
Kochanek Dermatology and Allergic Diseases, University of Ulm, Ulm, Germany
Mutations in the gene encoding CD18, the common β-chain of the β2 integrin family, result in severe
wound healing disturbances in human patients with leukocyte adhesion deficiency syndrome type
1 (LAD1). Previously, we have generated a CD18-deficient mouse strain, which revealed a severe
delay in healing of full-thickness wounds. Using a full-thickness excisional wound model in CD18-
deficient mice, we here demonstrate that adipose tissue derived mesenchymal stem cells (AT-MSCs)
can be successfully used for cell-based therapy to support healing of difficult-to-treat chronic wounds.
Notably, AT-MSCs injected around full-thickness wounds significantly accelerated wound healing
at all stages in CD18-deficient mice compared to wildtype control mice. AT-MSCs injection around
CD18-deficient wounds fully restored decreased TGF-β1 concentrations to that of wildtype mice.
The elevated TGF-β1 in CD18-deficient wounds was mainly contributed by TGF-β1 released by AT-
MSCs up to day 7 post-wounding, eventually leading to augmented myofibroblast differentiation as
indicated by increased expression of α-smooth muscle actin in the wound bed. These beneficial
effects were abolished when wounds were injected with TGF-β1 silenced AT-MSCs. Taken together,
these data suggest that local delivery of AT-MSCs may represent a promising tool to improve impaired
healing in chronic CD18-deficient wounds via the release of TGF-β1 and subsequent induction of
myofibroblast-dependent wound contraction. Given that decreased TGF-β1 levels also constitute a
major hallmark in the widely occurring chronic venous leg ulcer, our results even more are of par-
ticular clinical relevance.
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Bone morphogenetic protein signalling regulates keratinocyte proliferation and migration
during wound healing
CJ Lewis,2 AN Mardaryev,1 AA Sharov,3 TY Sharova,3 V Emelyanov,3 NV Botchkareva,1 DT Sharpe2
and VA Botchkarev1 1 Centre for Skin Sciences, Bradford University, Bradford, United
Kingdom, 2 Plastic Surgery & Burns Research Unit, Bradford University, Bradford, United
Kingdom and 3 Department of Dermatology, Boston University, Boston, MA
Bone morphogenetic proteins (BMPs) and their receptors (BMPRs) regulate tissue development; how-
ever, their role in wound healing remains unclear. To study the role of BMPs in skin repair, we used
transgenic mice overexpressing the BMP antagonist Noggin or BMP downstream component Smad1
under the control of a K14 promoter as in vivo models, as well as a human ex vivo wound healing
model. K14-Noggin mice displayed accelerated wound healing, associated with increased ker-
atinocyte proliferation at the wound edge and a hyper-proliferative wound epithelium, as well as
an increased wound capillary density versus controls. In contrast, K14-Smad1 mice exhibited delayed
wound healing and significantly reduced wound epithelial surface area, compared to controls. qRT-
PCR showed down-regulation of BMPR-IA and up-regulation of BMPR-IB in murine wounded skin,
as well as down-regulation of the BMP receptor ligands (BMP2/4/6/7). Flow cytometry revealed a
decrease of human and mouse keratinocyte proliferation after BMP4/7 treatment, whereas treatment
with Noggin increased proliferation. Silencing of BMPR-IA by siRNA increased keratinocyte prolif-
eration, whilst constitutive activation of both receptors reduced proliferation. Keratinocyte migra-
tion was decreased after treatment with BMP4/7 compared to controls. Furthermore, silencing of
BMPR-IB accelerated migration compared to controls, whilst targeted overexpression of BMPR-IA/IB
in conjunction with Smad1/5 attenuated migration. Topical administration of BMP4/7 to a human
ex vivo wound healing model impaired epithelial closure versus the controls, whereas treatment
with Noggin resulted in acceleration of epithelial closure. Thus, this study demonstrates that BMPs
negatively regulate keratinocyte proliferation and migration during wound healing, and raises a pos-
sibility for using BMP antagonists for the management of chronic wounds.
038 
MSCs Improve Impaired Wound Healing in an Iron-Overload Mouse Model via Suppression
of Unrestrained Macrophage Activation
Y Qi,1 A Sindrilaru,1 D Jiang,1 M Rojewski,2 H Hainzl,1 A Kügler,1 H Schrezenmeier2 and
K Scharffetter-Kochanek1 1 Department of Dermatology and Allergic Diseases, University of
Ulm, Ulm, Germany and 2 Department of Transfusion Medicine and Immunogenetics,
University of Ulm, Ulm, Germany
Previously, we showed that iron overloading of macrophages – as was found in human chronic
venous leg ulcers (CVU) and in the iron-overload mouse model – induced unrestrained macrophage
activation with excessive release of TNFα which perpetuates inflammation eventually - by so far
unknown mechanisms - leading to fibrosis with loss of the subcutaneous mesenchymal stem cell
(MSC) niche. We hypothesised that application of MSCs may represent a promising treatment to
suppress persistent macrophage activation and rescue the regenerative capacity of these difficult-
to-treat wounds. Macrophages exposed to Fe(III)-chloride/ascorbate and H2O2 in vitro, which mim-
ics the Fenton reaction in CVU in vivo, released high amount of proinflammatory TNFα. Notably,
co-incubation of “iron-macrophages” with MSCs resulted in a significant suppression of macrophage-
derived TNFα, while the release of antiinflammatory IL-10 was enhanced. To study the effect of
MSCs on macrophage activation and wound healing in vivo, full-thickness wounds were induced
on the back of iron-overload mice closely reflecting main pathogenic aspects of CVU. We found
that MSCs injected around wounds significantly accelerated wound healing in iron-overload mice
when compared to wounds injected with PBS or fibroblasts (FB). Acceleration of wound healing
was most likely due to the suppression of macrophage recruitment and activation at the wound
site. Indeed, compared to the wounds injected with FB or PBS, MSCs dramatically suppressed
TNFα release and the expression of CCR2 which is mainly responsible for macrophage recruitment
to the wound site. In addition, fibrogenic TGFβ1 expression was suppressed upon injection of MSCs,
indicating that - in addition to their antiinflammatory properties - MSCs may prevent scarring and
dermatoliposclerosis. Thus, application of MSCs may qualify as a promising therapy in macrophage
dominated impaired wound healing.
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A role of LYVE-1 in pathological lymphangiogenesis and psoriasis
S Hirakawa,1 H Nishida-Fukuda,2 M Detmar,3 S Higashiyama2 and Y Tokura1 1 Dermatology,
Hamamatsu Univ. School of Medicine, Hamamatsu, Japan, 2 Cell Growth and Tumor
Regulation, Ehime Proteo-Medicine Research Center, Toon, Japan and 3 Pharmacogenomics,
ETH Zurich, Zurich, Switzerland
Lymphatic vessel endothelial hyaluronan receptor (LYVE)-1 is a type I transmembrane protein that
is expressed in lymphatic capillaries in the skin. Although LYVE-1 is known as one of the most use-
ful lymphatic vessel-specific markers, the biological function of LYVE-1 remains unclear. Psoriasis
is a chronic inflammatory skin disease with pronounced angiogenesis. We previously showed that
targeted overexpression of VEGF-A in mice develops chronic skin alterations resembling psoriasis.
Furthermore, VEGF-A transgenic mice revealed pronounced lymphangiogensis in the skin, indicat-
ing that VEGF-A may induce lymphangiogenesis as well as angiogenesis. Therefore, we investi-
gated whether VEGF-A might modulate the expression and kinetics of lymphatic vessel-specific mol-
ecules such as LYVE-1 in psoriasis, and explored a potential mechanism of lymphangiogenesis.
VEGF-A induced the ectodomain shedding of LYVE-1 in cultured human lymphatic endothelial cells
(LECs). Cultured LECs were further subjected to an analysis of ectopic expression of wild-type or a
mutated form of LYVE-1 in the extracellular domain using adenoviral system. Wild-type, but not the
mutated form, of LYVE-1 underwent proteolytic cleavage in the presence of VEGF-A. Importantly,
wild-type LYVE-1 promoted enhanced migration of LECs in response to VEGF-A, whereas the mutated
form of LYVE-1 failed to induce the endothelial cell migration towards hyaluronan-coated trans-
membrane, indicating that ectodomain shedding of LYVE-1 is required to VEGF-A-induced migra-
tion of LECs. Moreover, double immunofluorescence stains for N- and C-terminus of LYVE-1 in
psoriatic lesions showed distinct patterns of localization in lymphatic vessels even though these
stains are merged in normal lymphatic vessels. Together, these results indicate that LYVE-1 under-
goes ectodomain shedding, and that the biochemical cleavage of LYVE-1 may contribute to migra-
tion of LECs during lymphangiogenesis and the pathogenesis of psoriasis.
035
Reduced production of IL17 distinguishes a wound associated population of Ly6clow MHCI-
Ihi macrophages promoting healing
M Rodero,1 S Hodgson,1 B Holier,2 C Combadiere3 and K Khosrotehrani1 1 The University of
Queensland Centre for Clinical Research, The university of queensland, Brisbane, QLD,
Australia, 2 QUT, Brisbane, QLD, Australia and 3 Inserm, Paris, France
Recently the importance of macrophages in generating pro-inflammatory but also pro-repair sig-
nals has been demonstrated. Given the heterogeneity of macrophage phenotypes-classically described
as M1 or M2- we hypothesized that these antagonistic functions would be carried by different
macrophage subpopulations that we aimed to characterize. Using flow cytometry on wound gran-
ulation tissue (gt), we showed that Ly6c and MHCII expression levels discriminate four populations
of wound associated macrophages with distinct infiltration patterns along the healing. Only the
Ly6clow MHCIIhi population correlated positively with wound closure. In accordance, this popu-
lation was significantly reduced in Ob/Ob mice with defective wound healing. Gene expression
array analysis of FACS sorted macrophage populations indicated that Ly6clow MHCIIhi macrophages
had reduced expression of a range of inflammatory molecules compared to other wound macrophage
populations. In particular, reduced IL17 expression clearly distinguished the Ly6clow MHCIIhi
population. We demonstrated that IL17 was mostly expressedduring the first three days following
wounding by infiltrating macrophages and myeloid cells but not by T cells. Most importantly, Il17-
/- mice displayed accelerated wound healing with increased levels of Ly6clow MHCIIhi cells in early
days of healing. In addition, blocking IL17 during initial steps of wound healing resulted in signif-
icant and sustained improvement of wound closure in Ob/Ob mice. In conclusions, we have iden-
tified distinct macrophage populations within skin wounds that have antagonistic roles. Blocking
IL17 might be a new strategy to improve defective wound healing possibly by promoting the switch
from inflammatory to Ly6clow MHCII hi macrophages.
039 
Cell-based regenerative medicine by nestin-positive stem cells: Promotion of human skin
wound healing in organ culture by pluripotent adult human progenitor cells isolated from
human sweat gland stroma
T Liao,1 A Yay,1 G Zhang,1 S Nagel,2 AE Petschnik,2 S Danner,2 C Kruse,2 S Tiede1 and R Paus1 1
Dermatology, University of Lübeck, Lübeck, Germany and 2 Fraunhofer Research Institution
for Marine Biotechnology (EMB), Lübeck, Germany
Chronic human skin wound healing presents a major problem in clinical medicine, therefore novel
strategies can promote the reepithelialisation, angiogenesis and granulation tissue formation of
skin wound healing are urgently required. Previously, we established a “punch-within-a-punch”
serum-free organ culture of full-thickness human skin wound healing model for probing cell-based
regenerative medicine approaches that exploit adult human skin progenitor cells. To trace trans-
planted human nestin+ progenitor cells isolated from human sweat gland stroma (Nestin+-SGSCs),
nanoparticles or DiI were used. While nanoparticles got quickly lost, DiI-labelled nestin+-SGSCs
remained traceable 6 days after transplantation. Just as we had previously seen with nanoparticle-
labelled nestin+-SGSCs, DiI-labelled nestin+-SGSCs accelerated reepithelialisation, proliferation
and terminal differention (involucrin expression) in the newly regenerated epithelium as well as
angiogenesis in organ-cultured human wounded skin. Moreover, transplantation of DiI-labelled
nestin+-SGSCs also stimulated granulation tissue formation, as indicated by an increased number
of CD90+ fibroblasts, MHC class II+ macrophages/DC and c-Kit+ mast cells compared to controls.
This underscores the promise of adult human nestin+-SGSCs for cell-based human skin regenera-
tive medicine and shows DiI-labelling of these cells can trace their fate in situ. This facilitates meet-
ing the next challenge, i.e. to clarify whether these progenitor cells of human skin stroma differen-
tiate after transplantation into various cell lineages required for optimal wound healing, or whether
they primarily induce resident progenitor cells to do so.
www.jidonline.org   S7
ESDR12_Abstracts-3  7/20/12  1:26 PM  Page S7
ABSTRACTS | Angiogenesis, Vascular Biology and Wound Healing 
040 
MFG-E8 promotes wound healing in murine skin
S Motegi,1 A Uchiyama,1 K Yamada,1 S Ogino,1 Y Takeuchi,1 MC Udey2 and O Ishikawa1 1
Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi,
Japan and 2 Dermatology Branch, Center for Cancer Research, National Cancer Institute,
NIH, Bethesda, MD
MFG-E8 is a secreted glycoprotein that is comprised of 2 N-terminal EGF-like domains and 2 C-ter-
minal discoidion domains. One EGF-like domain contains an RGD sequence that binds to αvβ3/5
integrins. Recently we demonstrated that pericytes produced MFG-E8 in B16 melanoma tumors,
that this αv ligand enhanced angiogenesis, and that MFG-E8 increased platelet-derived growth fac-
tor receptor β (PDGFRβ) signaling mediated via integrin-growth factor receptor cross talk. However,
functions of MFG-E8 in angiogenesis in cutaneous wound healing are not well characterized. The
objective of this study was to ascertain the role of MFG-E8 in cutaneous wound healing. At first, we
examined the distribution of MFG-E8 in normal murine and human skin in vivo. In the dermis, accu-
mulations of MFG-E8 were found around CD31+ blood vessels, but not lymphatics. MFG-E8 co-
localized with PDGFRβ+ pericytes in the dermis, and MFG-E8 deposits frequently observed near
vascular branch points. These results are consistent with our previous studies identifying pericytes
as important sources of MFG-E8 in melanoma tumors in vivo. Next, we examined the role of MFG-
E8 using cutaneous wound healing mice model. Protein and mRNA level of MFG-E8 expression in
dermis was enhanced during wound healing detected by immunofluorescence staining and real-
time PCR. In addition, MFG-E8 diffusely localized in granulation tissue as well as around blood
vessels in dermis. In preliminary experiments, wound healing was delayed in MFG-E8 KO mice
compared with that in WT mice. We conclude that MFG-E8 promotes wound healing in murine
skin, perhaps by regulating angiogenesis. Abnormalities in MFG-E8 production or function may con-
tribute to the pathogenesis of non-healing wounds, including diabetic and decubitus ulcers.
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High levels of onco-miR-21 contribute to a senescence–like growth arrest in normal human
endothelial cells and fibroblasts
M Wieser,1 F Gruber,2 E Tschachler,2 R Grillari-Voglauer1 and J Grillari1 1 Department of
Biotechnology, BOKU - VIBT, Vienna, Austria and 2 Department of Dermatology, Medical
University Vienna, Vienna, Austria
Cellular senescence of normal human cells has by now far exceeded its initial role as a model sys-
tem for aging research. Many reports show the accumulation of senescent cells in vivo, their effect
on their microenvironment and its double edged role as tumour suppressor and promoter. In addi-
tion, removal of senescent cells delays the onset of age-associated diseases. In order to character-
ize the role of miRNAs in cellular senescence of fibroblasts and endothelial cells, we performed
miRNA arrays from HUVECs of 5 different donors. Twelve miRNAs, comprising hsa-miR-23a, hsa-
miR-23b, hsa-miR-24, hsa-miR-27a, - hsa-miR-29a, hsa-miR-31, hsa-miR-100, hsa-miR-193a, hsa-
miR-221, hsa-miR-222 and hsa-let-7i are consistently up-regulated in replicatively senescent cells.
Surprisingly, also miR-21 was found up-regulated by replicative and stress induced senescence,
despite being described as one of the first oncomiRs. Transfection of miR-21 into early passage
endothelial cells resulted in lower angiogenesis, and less cell proliferation mirrored by up-regula-
tion of p21CIP1 and down-regulation of CDK2. These two cell cycle regulators are indirectly regu-
lated by miR-21 via its validated direct targets NFIB that inhibits p21CIP1 transcription and CDC25A,
which regulates CDK2 activity by dephosphorylation. Knock-down of either NFIB or CDC25A show
a phenocopy of overexpressing miR-21 in regard to cell cycle arrest. It is of note that miR-21 has
been mainly found as an oncogene that is also induced by H-RAS. Therefore, we propose that miR-
21 is the first miRNA, whose overexpression alone might represent a hyperoncogenic signal in nor-
mal cells similar to constitutively active H-RAS.
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sVEGFR-1/α5β1 integrin interaction triggers an endothelial cell dynamic and angiogenic phe-
notype
A Orecchia,1 A Mettouchi,3 P Uva,4 G Simon,5 S Avitabile,1 G Ragone,2 G Meneguzzi,3
K Pfenninger,5 G Zambruno1 and CM Failla1 1 Molecular and Cell Biology Lab., IDI-IRCCS,
Rome, Italy, 2 Molecular Oncology Lab., IDI-IRCCS, Rome, Italy, 3 U634, Inserm, Nice,
France, 4 CRS4 Bioinformatics Lab., Polaris Science and Technology Park, Cagliari, Italy and
5 Department of Pediatrics, University of Colorado, Aurora, CO
sVEGFR-1 acts both as a decoy receptor for VEGFs and as an atypical ligand for α5β1 integrin. A
sVEGFR-1-derived peptide that interacts with α5β1 integrin promotes angiogenesis, but the inte-
grin-mediated canonical signals are not induced, resulting in delayed focal adhesion maturation.
We performed a gene expression profile of endothelial cells adhering to sVEGFR-1, to fibronectin,
a classical extracellular matrix ligand for α5β1 integrin, or in non-adhering conditions. We identi-
fied several biological pathways that were differently modulated and three protein kinase-C sub-
strates, adducin, MARCKS, and radixin, were differently phosphorylated when sVEGFR-1 adhering
cells were compared to those adhering to fibronectin. Rac1 activation and a Gα13 protein involve-
ment were also detected after adhesion on sVEGFR-1. As a consequence, endothelial cells exhib-
ited dynamic adhesions that sustained a more motile phenotype. Moreover, our data reveal a novel
network in which radixin is accountable for the angiogenic effect of α5β1 integrin interaction with
sVEGFR-1 that, in turn, depends on active VEGF-A/VEGFR-2 signaling.
043
Inhibition of angiogenesis in lymph node metastasis
R Aki,1 Y Amoh,1 H Kishimoto,2 H Kimura,2 A Suetsugu,2 M Momiyama,2 K Katsuoka1 and
RM Hoffman2 1 Dermatology, Kitasato University School of Medicine, Kanagawa, Japan and 2
AntiCancer, Inc., San Diego, CA
Cancer invasion of the lymphatic system and spread to draining lymph nodes is a common occur-
rence and is often a first step of the metastatic pathway. Suppression of tumor angiogenesis in the
lymph node should inhibit cancer growth and further spread from the lymph node. In the present
study, we evaluated angiogenesis inhibitors in lymph node metastasis using GFP imaging. Trans-
genic nude mice expressing GFP under the control of the nestin promoter (ND-GFP mice) were used
as hosts. Nascent blood vessels express GFP in these mice (Cancer Res. 65, 5352-5357, 2005).
B16F10-RFP mouse melanoma cells were injected into the efferent lymph vessel of the inguinal
lymph node of the transgenic ND-GFP nude mice to establish experimental metastasis in the axil-
lary lymph node. The mice were given daily i.p. injections of doxorubicin or vehicle controls at days
0, 1, and 2 after implantation of tumor cells. The axillary lymph nodes of the mice were observed
at day 8 after injection of tumor cells. Angiogenesis was quantified in the tumor-involved lymph
node by measuring the total length of ND-GFP nascent blood vessels. The number of ND-GFP-
expressing blood vessels in the tumor-involved lymph nodes was significantly less in the doxoru-
bicin-treated animals than in vehicle control mice. Treatment with doxorubicin significantly decreased
the volume of the metastatic axillary-node tumor as well as nascent blood vessel formation. These
results show the utility of the dual-color ND-GFP-mouse and RFP-cancer-cell model to visualize
and quantitate angiogenesis in tumor-involved lymph nodes and to screen for angiogenesis inhibitors
at this site.
044
Epidermal MMP-14 expression during wound healing modulates angiogenesis but not re-
epithelialization
P Zigrino,1 O Ayachi,1 A Schild,1 J Kaltenberg,2 J Zamek,1 R Nischt,1 M Koch3 and C Mauch1 1
Department of Dermatology and Venerology, University of Cologne, Cologne, Germany, 2
Center for Biochemistry, University of Cologne, Cologne, Germany and 3 Institute for Dental
Research and Musculoskeletal Biology and Center for Molecular Medicine Cologne,
University of Cologne, Cologne, Germany
Activities of matrix metalloproteinases during wound healing are important for several processes
including remodeling the extracellular matrix and modulation of cellular functions. Previous reports
indicated that epidermal outgrowth from skin specimens of the MMP-14 knockout mice was sig-
nificantly reduced than control specimens. However, in the above system it is not possible to exclude
that ablation of MMP-14 in the dermal compartment also contributes to the observed phenotype.
To analyze the function of epidermal MMP-14 during skin repair we generated mice lacking MMP-
14 expression in the epidermis (MMP-14ep-/-). These mice displayed overall normal skin morphology
and epidermal differentiation patterns. Wound repair in MMP-14ep-/- followed the same kinetics
as in wild type mice (MMP-14ep+/+) and re-epithelialization, epidermal differentiation and gran-
ulation tissue formation was comparable. In addition, in vitro, murine keratinocytes isolated from
complete as well as epidermis-specific knock-out mice revealed no changes in migration on colla-
gen type I compared to control cells. Microscopic analysis showed no altered re-epithelialization
in the absence of epidermal MMP-14. However, at day 14 post wounding, sustained angiogenesis
was observed in MMP-14ep-/- mice in contrast to control mice. Interestingly, decreased levels of
endostatin were detected in wound lysates of MMP-14ep-/- mice as well as in cultured keratinocytes.
Taken together, these data indicate that MMP-14 expression in keratinocytes is dispensable for skin
homeostasis and repair, but plays a crucial role in the epidermal-dermal crosstalk leading to mod-
ulation of vessel density.
045
Adenosine A2A receptors promote wound healing by modulating miR-29a signaling
RC Radusky, BN Cronstein, ES Chan, M Perez – Aso and AG Franks Medicine, New York
University School of Medicine, New York, NY
We have previously demonstrated that the nucleoside adenosine mediates collagen production
and induces dermal fibrosis in vitro and in vivo. miR-29a has recently been shown to be downreg-
ulated in scleroderma skin sections. However, the mechanisms involved are unclear. Our aim is to
further characterize the contributions of endogenous adenosine and adenosine A2A receptors to
fibrous matrix production in the skin via miR-29a signaling. In this investigation, human dermal
fibroblasts were treated with A2A receptor agonist (CGS-21680, 1μM) and/or A2A receptor antag-
onist (ZM241385, 1μM). Changes in miR-29a expression were analyzed by real-time PCR at 2 hours.
A2A receptor stimulation induced a 48.6% reduction in the expression of miR-29a. Cotreatment
with A2A receptor antagonist completely reversed this effect, while antagonist alone had no effect.
In vivo investigation yielded parallel results. 12mm incisional wounds were induced in a total of
32 C56BL/6 mice . Mice were treated with either the A2A receptor antagonist or vehicle, dimethyl
sulfoxide (DMSO), alone as a control. Wound–healing progression was quantified using trichrome
staining. A qualitative decrease in collagen deposition was noted in mice treated with the A2A recep-
tor antagonist compared with untreated control mice. Changes in miR-29a expression were ana-
lyzed at the end of the investigation. Blockade of the adenosine A2A receptor in the mouse model
is associated with a 68.2% increase in expression of miR-29a compared with those treated with
DMSO alone (p <0.05). These findings suggest that the A2A receptor or miR-29a may be novel ther-
apeutic targets to promote wound healing.
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Flightless neutralizing antibodies improve healing of blistered skin
Z Kopecki,1 N Ruzehaji,1 C Turner,1 H Iwata,2 RJ Ludwig,2 D Zillikens,2 DF Murrell3 and AJ Cowin1
1 1Women’s and Children’s Health Research Institute, 72 King William Road, North Adelaide,
SA, Australia, 2 2Department of Dermatology, University of Lubeck, Lubeck, Germany and 3
3Department of Dermatology, St George Hospital, Sydney, NSW, Australia
The actin remodeling protein Flightless (Flii) is a contributing factor to increased dermal-epidermal
separation during skin blistering with increased levels of Flii in the blistered skin of EB patients and
EB mouse models including genetic recessive dystrophic EB (RDEB) and immune-mediated EB
acquisita (EBA). Using a mouse model of EBA we have now investigated the effect of reducing Flii
in skin by topically applying Flii neutralizing antibodies (FnAb) in a cream vehicle. We demon-
strate that FnAb cream reduces Flii expression in the skin and that repeated application of FnAb
cream during blister development and healing of blisters significantly decreases the size and num-
ber of skin blisters with observed improvements in the rate of healing. Reformation of the skin’s bar-
rier function is also improved with significantly reduced trans-epidermal water loss observed fol-
lowing treatment with FnAb cream. Application of FnAb cream to blistered skin also reduces the
skin’s fragility demonstrating a functional effect of treatment on the skin and suggesting that FnAb
may have potential for use to treat patients suffering from EB.
048
The connexin mimetic peptide Gap27 improves cell motility in human skin models despite
raised glucose, insulin and IGFBP-5
CS Wright,1 DJ Flint2 and PE Martin1 1 Department of Life Sciences, Glasgow Caledonian
University, Glasgow, United Kingdom and 2 Strathclyde Institute of Pharmacy and Biomedical
Sciences, University of Strathclyde, Glasgow, United Kingdom
In chronic non-healing diabetic wounds Connexin43 (Cx43) is upregulated at the wound edge com-
pared to ‘normal’ skin wounds. Reduced Cx43 expression/function is associated with improved
wound closure rates, consistent with our data to date showing that the Cx43 channel blocker, Gap27,
increases scrape-wound closure rates in human skin models. Insulin Growth Factor-I (IGF-I) also
stimulates skin wound healing whilst its actions can be attenuated by IGF binding protein 5 (IGFBP-
5). The IGF-I:IGFBP-5 ratio is altered in diabetic skin and maybe of clinical significance. We inves-
tigated whether Gap27 remains effective in improving scrape-wound closure rates in organotypic
and cell monolayer human skin models designed to simulate these diabetes-induced changes in
skin using culture conditions with raised glucose, insulin and IGFBP-5. Gap27 increased cell migra-
tion rates in both normal glucose and insulin (NGI) and high glucose and insulin (HGI) conditions;
IGF-I augmented migration of Gap27-treated cells further, whereas IGFBP-5 retarded them. Gap
junctional intercellular communication (GJIC) was reduced in HGI, and Gap27 significantly decreased
GJIC in both NGI and HGI. IGF-I and IGFBP-5 did not affect keratinocyte GJIC or hemichannel activ-
ity. IGF-I increased keratinocyte proliferation in NGI and Gap27 increased proliferation in both NGI
and HGI. These results indicate that Gap27 can override inhibitory effects of IGFBP-5 on cell
migration. Scrape-wound closure occurs as a combination of cell migration and proliferation, which
are stimulated independently by IGF-I and Gap27; Gap27 acting via inhibiting Cx43 function. We
conclude that Gap27 should enhance wound closure in diabetic conditions where the IGF-I:IGFBP-
5 balance is disturbed.
050
Development of full-thickness skin equivalents including immunological cell types
S Kurdyn,1 F Weil,2 S Mielke,2 J Nickel1 and H Walles1 1 Department for Tissue Engineering and
Regenerative Medicine, University Hospital, Würzburg, Germany and 2 Department of
Internal Medicine II, University Medical Center, Würzburg, Germany
Besides the goal of developing skin grafts, the use of artificial skin equivalents (SEs) as in vitro test
systems for medical investigations of skin-related issues is also of increasing dermatological rele-
vance, particularly in regard to the 7th Cosmetic Directive in 2009 and the EU directive REACH.
The last years, enormous progress was made in the creation of SEs using primary skin cells in com-
bination with dermal scaffolds, especially in the development of full-thickness SEs (fSEs). However,
currently available SEs are just simplified models as they’re lacking crucial and characteristic struc-
tures like hair follicles and sweat glands. So far, no validated SE contains cells of the immune sys-
tem, even though inflammation and allergic reactions are important mechanisms of the barrier func-
tion of human skin. We developed methods to integrate either lymphocytes or macrophages into
fSEs. Keratinocytes and fibroblasts were isolated from human skin biopsies. Immune cells from other
sources were isolated from buffy coats using ficoll gradient centrifugation and macrophages further
purified by plastic adherence. Fibroblasts mixed with immune cells were integrated into dermal col-
lagen-based matrices with consistent cell distribution. After overlaying these matrices first with
fibronectin and finally with keratinocytes, the SEs were cultured under submersed conditions for 7
days, followed by 14 days at an air-liquid interface to allow an epidermal differentiation and devel-
opment of stratified layers. SEs including immunological cell types were histologically and immunhis-
tologically characterized by HE- and IF-staining using various tissue- and cell-specific markers.
Further optimization of the co-culture methods are under investigation and molecular technologies
as qPCR and in-situ hybridization will be standardized to characterize the “immune-competent”
SEs. Such a model would provide a powerful tool for the investigation of chronic wounds and
immune-inflammatory infections in skin.
049
Regulation of keratinocyte migration by podoplanin during cutaneous wound healing in
mice
J Asai,1 S Hirakawa,3 J Sakabe,3 T Kishida,2 O Mazda,2 T Urano,4 K Suzuki-Inoue,5 Y Tokura3 and
N Katoh1 1 Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2
Immunology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3 Dermatology,
Hamamatsu University School of Medicine, Hamamatsu, Japan, 4 Physiology, Hamamatsu
University School of Medicine, Hamamatsu, Japan and 5 Clinical and Laboratory Medicine,
Faculty of Medicine, University of Tamanashi, Kofu, Japan
Podoplanin, a transmembranous glycoprotein, is known as a lymphatic endothelial specific marker
in physiological condition. Recent evidence indicates that podoplanin is also markedly expressed
by keratinocytes at the leading edge of regenerated epidermis during cutaneous wound healing.
However, it remains to be elucidated whether podoplanin plays a functional role in keratinocytes
during wound healing. We sought to clarify the biological function of podoplanin in keratinocytes,
focusing on their migration during wound healing. We created full-thickness wound on the dorsal
skin of mice and evaluated the expression intensity of podoplanin at differential time points.
Podoplanin expression was highly upregulated at day 3 after wounding, and decreased thereafter.
Transfection of podoplanin siRNA inhibited the migration of cultured normal human epidermal
keratinocytes (NHEK), indicating that podoplanin plays a mandatory role in migration of keratinocytes.
Podoplanin is identified as an endogenous ligand for C-type lectin-like receptor 2 (CLEC-2), which
is expressed on platelets. We therefore investigated whether CLEC-2/podoplanin interaction might
regulate the migration of cultured NHEK. The extracellular domain of human CLEC-2 is expressed
as a soluble form. The CLEC-2 soluble protein was fused to dimeric rabbit immunoglobulin Fc domain
to form fusion protein (hCLEC-2-rFc2), and it was administered to NHEK. However, the migration
of NHEK remained unchanged irrespective of the presence of hCLEC-2-rFc2. These results suggest
that podoplanin mediates keratinocytes migration in a CLEC-2 independent manner during wound
healing, and that the podoplanin regulation of keratinocytes might be a novel therapeutic potential
in impaired wound healing.
047
Vascular Endothelial Growth Factor correlates with skin and systemic manifestation in Fabry
disease
M Gnarra,1 A Zampetti,1 D Antuzzi,2 C Cadeddu,3 C de Waure3 and C Feliciani1 1 Dermatology,
Policlinico A. Gemelli-Catholic University, Rome, Italy, 2 Pediatric Science, Policlinico A.
Gemelli-Catholic University, Rome, Italy and 3 Hygene, Policlinico A. Gemelli-Catholic
University, Rome, Italy
Purpose of this study was to analyse VEGF-A expression in patients with Fabry disease (FD) and
healthy controls, and to correlate the cytokine levels with FD cutaneous and systemic manifesta-
tions. Thirty-five FD patients, along with an age- and gender matched control group, were enrolled
in this study. Serum samples were collected for VEGF-A levels detection trough ELISA. Results were
associated and analysed with Fabry patients genetic mutations (assessed by molecular analysis),
gender, specific organ dysfunction markers, and cardiovascular risk factors. Presence of FD der-
matological signs, including angiokeratomas (AGK), FaciesFabry (FF), sweating abnormalities (hyper-
hidrosis/hypohidrosis) and telangiectasia was evaluated and dermoscopy analysis of AGK was con-
ducted. VEGF-A mean serum levels in Fabry patients was significantly higher than in healthy controls
(p=0,006). A statistical significant correlation was also found between VEGF levels and GLA muta-
tions (p=0,03), male gender (p=0,001), AGK (p=0,2), sweating abnormalities (p=0,02), FF (p=0,01),
retinal vessel tortuosity (p=0,008), proteinuria (p=0,03), stroke (p=0,05), hypertension (p=0,03), and
smoking habit (p=0,02). Increased VEGF-A serum levels in FD could be explained as the response
to the damage induced by glycolsphingolipids into the vascular endothelium, hallmark of FD.
Interestingly, VEGF-A is also overexpressed by keratinocytes in skin disease with proliferation and
vascularization such as psoriasis and infantile Haemangiomas. Therefore, VEGF-A could play an
important role in AGK pathogenesis and therefore anti-VEGF molecules can also represent a poten-
tial treatment for the cutaneous and systemic manifestations of Fabry disease.
051
Development of a vascularized skin equivalent with a physiological perfused vascular net-
work
FK Groeber,1 J Hansmann2 and H Walles2 1 Institute for Interfacial Engineering, University of
Stuttgart, Stuttgart, Germany and 2 Cell and Tissue Engineering, Fraunhofer-Institute for
Interfacial Engineering and Biotechnology, Stuttgart, Germany
The objective of this study was to develop a vascularized skin equivalent (SE) that allows the anas-
tomosis of the formed vascular system with an outer blood stream. Therefore, a biological vascu-
larized scaffold (BioVaSc) based on a decellularized porcine jejunum was developed that allows
the reseeding of the vascular structures, embedded in the scaffold, with human endothelial cells
and the connection of the vascular network with an outer bloodstream. For the formation of skin
tissue the BioVaSc was additional inoculated with human fibroblasts and keratinocytes and inte-
grated into a new custom made bioreactor system that allows the culture of the vascularized skin
substitute both under submersed conditions and at the air-liquid interface. Furthermore, the biore-
actor system allows the pulsatile perfusing of the vascular structures under physiological pressure
conditions between 80 and 120 mmHg. After culturing the vascularized SE at an air-liquid inter-
face for 12 days in the bioreactor system, histological hemalaun/ eosin (HE) and immunohistolog-
ical staining revealed a naturally differentiated and well stratified epidermal layer of keratinocytes
on top of the BioVaSc and equally distributed fibroblasts inside of the scaffold. Due to the villi
structure of the BioVaSc, the epidermis of the SE on top of the BioVaSc exhibits a papillary like archi-
tecture as seen in vivo. In addition the endothelial cells were able to recolonize the perfused vas-
cular structures inside the scaffold as visualized by HE staining and confocal laser scanning
microscopy. Using a biological vascularized scaffold in combination with a new developed biore-
actor system this study shows first time the in vitro generation of a vascularized SE with a perfused
vascular network, that is capable of anastomosis.
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Identification of a chemokine profile during progression of primary human melanoma
A Soler Cardona, A Bracher and R Loewe Dermatology, Medical University Vienna, Vienna,
Austria
Metastasis in melanoma requires a complex series of steps covering interconnected processes such
as angiogenesis, lymphangiogenesis, tumor and host immunology or tumor cell migration. Crucial
for its understanding is the study of molecules linking these processes. Chemokines are important
mediators in nearly all the above mentioned steps. In a xenotransplantation melanoma mouse model,
the chemokine profile of primary tumors and lymph node metastasis was compared to controls.
Expression of twelve chemokines in mRNA level proved to be differently regulated. These chemokines
were subsequently analyzed in FFPE samples of human stage T1 to T4 melanomas using RT-PCR.
Interestingly, a chemokine pattern primarily reflecting differences in biological behavior and not
only the different tumor stages could be identified. From the upregulated chemokines we focused
in those involved in the metastatic process through cell migration and angiogenesis/lymphangio-
genesis. An increased mRNA level could be identified even in metastasizing T1 melanomas. To proof
the biological relevance in vivo, overexpression was carried out in cell lines with diverse metasta-
tic behaviors including two primarly isolated from the same melanoma tumor patient and studied
in a xenotransplantation SCID mouse model.
053
Histologic and Molecular Analysis after Fractional Laser Resurfacing Using Skin Explants
G Park, J Kim, M Kim, S Bang, S Chang, C Won, M Lee, J Choi and K Moon Dermatology, Asan
medical center, Seoul, Republic of Korea
Fractional laser resurfacing (FR) is under extensive clinical investigation, but the molecular mech-
anism underlying this process is unknown. It seems to result from the ethical and cosmetic prob-
lems of skin biopsy required to study the changes after laser treatment. The purpose of this study
was to evaluate the usefulness of skin explants in the investigation after FR treatment, and to inves-
tigate the expression of candidate genes in FR-treated human skin. The human skin explants made
by various methods were treated with FR devices, and evaluated in morphological and functional
changes. Morphologic changes were observed for up to 1 week. CO2 FR-irradiated human skin
explants were investigated with gene microarray techniques after 2 and 24 hours. Results were val-
idated by real time RT-PCR. Laser-scanning confocal microscopy was used to investigate the expres-
sion of validated proteins after CO2 FR treatment of skin biopsied from 7 patients. Human skin
explants underwent the wound healing processes morphologically similar but not same with those
of in vivo human skin after treatment. Gene expression profiling showed that the most significantly
upregulated genes in these skin samples were those encoding Wnt5a, the cysteine-rich angiogenic
inducer 61 (CYR61), and heat shock protein (HSP) 90. These results were confirmed by real time
RT-PCR. On the laser-scanning confocal microscopy, the expressions of Wnt5a and CYR61 were
upregulated, but HSP90 showed no significant change. We concluded that the skin explant model
may be a useful tool for investigation about the early changes after laser treatment. Irradiation with
a CO2 FR treatment may induce the expression of Wnt5a and CYR61 in human skin during early
remodeling phases, suggesting that these proteins may be associated with the beneficial effects of
laser treatment.
054
Effect of Topical Tacrolimus on Cutaneous Wound Healing
S Namkoong,1 J Kim,1 J Kim,1 J Gye,1 S Ahn,2 B Park,1 M Kim1 and S Hong1 1 Dermatology,
Dankook University, College of Medicine, Cheonan, Republic of Korea and 2 Dermatology,
Yonsei University Wonju College of Medicine, Wonju, Republic of Korea
Topical tacrolimus is one of the main therapeutic modalities for atopic dermatitis. It is expected to
be increased in use for other inflammatory skin conditions due to its similar effects with that of glu-
cocorticoid. However, so far as we know there was little information about its effect on skin wound
healing, which is considered as one of the skin barrier recoveries. Therefore, we sought to deter-
mine whether the topical tacrolimus would have a positive or negative effect in acute cutaneous
wound healing. Two round full-thickness skin wounds were placed on the backs of 45 SKH-1 hair-
less mice which were divided into three groups (vehicle-treated, topical tacrolimus-treated, and top-
ical steroid-treated, n=15 in each). Mice were topically treated with petrolatum (control vehicle),
tacrolimus 0.1%, or clobetasol propionate 0.05% (highly potent glucocorticoid). The wound area
was assessed by using quantitative analysis of digital dermoscopic images every two days after
wounding. At 3, 7, and 11 days after wounding, 6 wounds of 3 mice in each group were taken for
semi-quantitative analysis of the histological features including re-epithelization, polymorphonu-
clear leucocytes (PMNL), fibroblasts, and collagen. We also checked the mRNA expression level of
EGF, TGF-β, TNF-α, and IL-1α. Unlike clobetasol propionate, topical tacrolimus did not delay
acute wound healing and showed normal time course of healing just like the vehicle. While topi-
cal application of clobetasol propionate was found to delay re-epithelialization and infiltration of
PMNL and attenuate the proliferation of fibroblast, topical treatment with tacrolimus showed pat-
terns similar to vehicle. In tacrolimus treated group, mRNA expression level of IL-1α and TGF-β
somehow decreased. Others were similar to vehicle treated group. In conclusion, topical tacrolimus
did not disturb wound healing process in an excisional murine skin wound model.
055
Psoriasin (S100A7) promote VEGF expression and angiogenesis in psoriasis
J Vegfors, D Verma, A Ekman and C Enerbäck Ingrid Asp Psoriasis Research Center, Department
of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden
The S100 calcium-binding protein family is involved in a number of cellular processes such as cel-
lular differentiation, energy metabolism and cell cycle progression. Psoriasin, S100A7, was initially
identified as a gene highly expressed in psoriasis. We have previously shown that psoriasin is induced
by reactive oxygen species (ROS) and that the downregulation of endogenous psoriasin expression
in a cancer cell line inhibited tumor growth in vivo. In accordance with these findings, we demon-
strated the downregulation of vascular endothelial growth factor (VEGF) in cells with reduced pso-
riasin levels. These findings raised the hypothesis that psoriasin may promote angiogenesis. Vascu-
lar modifications occur early in the development of psoriasis, suggesting that angiogenesis is one
of the key features in the pathogenesis of psoriasis. We recently showed that psoriasin interacts
with the multiligand receptor for advanced glycation end products (RAGE) providing endothelial
cell proliferation. The purpose of this study was to investigate the role of psoriasin in the mediation
of angiogenesis in psoriasis. We show that psoriasin induces dermal derived endothelial cell pro-
liferation and migration, demonstrated by the expression of proliferation markers, tube formation
and by scratch assay. IL-17, a key cytokine in psoriasis that has been shown to have a role in medi-
ating angiogenesis, strongly induces psoriasin leading to increased expression of angiogenic fac-
tors including VEGF in keratinocytes. Treatment with siRNA directed against psoriasin prevents the
induced expression of angiogenic factors. In conclusion, we show that psoriasin induces angiogenic
factors in keratinocytes and mediates endothelial cell proliferation and migration. Psoriasin may
therefore play a role in psoriasis by promoting oxidative stress response and angiogenesis.
056
Expression and regulation of cathelicidin in keratinocytes from patients with epidermolysis
bullosa
C Hüttner,1 C Gruber,1 R Lang,2 J Breitenbach,1 H Hintner1 and JW Bauer1 1 Department of
Dermatology, Division of Molecular Dermatology and EB House Austria, Paracelsus Medical
University, Salzburg, Austria and 2 Department of Dermatology, Paracelsus Medical
University, Salzburg, Austria
Epidermolysis bullosa (EB) is an inherited disease characterized by blisters and erosions on skin
and mucous membranes after minimal trauma. Most forms of EB show serious chronic wounds and
bacterial infections often complicate the healing process. Therefore we investigated the expression
level of cathelicidin (hCAP18), an important antimicrobial peptide (AMP) in keratinocytes which is
also known to contribute to a better wound healing. We found a reduced expression of hCAP18 in
different RDEB keratinocyte cell lines compared to a wildtype control (WT) by Real time PCR.
Western Blot analysis also indicated a differential regulation on the protein level. From these data
we conclude that reduced expression of hCAP18 in RDEB patients may render them more suscep-
tible to bacterial infections and consequently to poor wound healing. To investigate whether cal-
cipotriol, a vitamin D analogue, is able to enhance cathelicidin expression in RDEB keratinocytes
and to influence cell proliferation, WT and RDEB keratinocytes were treated with different con-
centrations of calcipotriol (1nM, 10nM, 100nM and 1μM). We observed upregulation of catheli-
cidin mRNA as well as of protein levels in WT and RDEB keratinocytes after calcipotriol treatment.
Moreover, proliferation assays (MTT assays) show a pro proliferative effect on keratinocytes after 48
hour treatment with 1nM calcipotriol. In summary, our results show that calcipotriol is able to upreg-
ulate cathelicidin expression and proliferation in RDEB keratinocytes. Therefore, calcipotriol might
be an interesting and promising potential therapeutic tool for clinical application in patients with
epidermolysis bullosa.
057
Effects of neuromediators and Nerve Growth Factor on skin wound healing
J Chéret, N Lebonvallet, C Le Gall-Ianotto and L Misery Laboratory of Neurosciences of Brest
(EA4685), University of Western Brittany, Brest, France
Close interactions exist between primary afferent fibers of the peripheral nervous system (PNS) and
skin cells. The PNS may be implicated in the modulation of different skin functions as wound heal-
ing. In order to study this influence, we have incubated human skin explants (punchs) mechani-
cally injured with different neuropeptides (Vasoactive Intestinal Peptide or VIP, Calcitonin Gene-
Related Peptide or CGRP, Substance P or SP) and the Nerve Growth Factor (NGF) at various
concentrations, and evaluated several parameters. Thus, we studied the effects of these molecules
physiologically secreted by sensory nerves endings in the skin on cell proliferation (Ki-67 incorpo-
ration), on the evolution of the ratio between type I and III collagens (immunohistochemistry), and
on the adhesion capacity (acid phosphatase assay), as well as differentiation into myofibroblasts
(expression level of α-SMA by PCR quantitative) of dermal fibroblasts. NGF and these neurotrans-
mitters increased fibroblasts proliferation and the expression levels of type I and III collagens accord-
ing to concentrations and incubation times, particularly between the 3rd and 7th day of culture (pro-
liferation phase). This last result was particularly interesting because collagen III is the first type of
collagen synthetized after injury, before its progressive replacement by collagen I. NGF and neu-
rotransmitters also increased the adhesion of fibroblasts and their differentiation into myofibrob-
lasts. The most potent concentrations for each tested molecules, were the lowest concentrations,
corresponding to the physiological concentrations. Thus, the PNS, through the release of NGF and
neurotranmsitetrs, is able to promote skin wound healing.
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Soluble GnT-V shift toward M2 macrophage in transgenic mouse skin
A Kato,1 M Terao,1 A Kimura,1 M Yutani,1 H Murota,1 E Miyoshi2 and I Katayama1 1 Dermatology,
Osaka University Graduate School of Medicine, Suita, Japan and 2 Molecular Biochemistry
and Clinical Investigation, Osaka University Graduate School of Medicine, Suita, Japan
Oligosaccharides are involved in a variety of human diseases. Glycosyltransferases are present in
the Golgi apparatus and are released from cells after cleavage in pathological conditions. N-acetyl-
glucosaminyltransferase V (GnT-V) is involved in the biosynthesis of beta1-6GlcNAc branching on
N-glycans and has been implicated in tumor progression and metastasis. Recently, we have found
that GnT-V is also involved in skin homeostasis. In contrast, a secreted type of GnT-V (soluble GnT-
V) itself is reported to promote angiogenesis, which is completely different from its original func-
tion as a glycosyltransferase (JBC 277, 2002), and this might also play a role in tumor invasion,
metastasis, and wound healing. In this study, we further explored the novel function of soluble
GnT-V (sGnT-V) by analyzing the skin phenotype of sGnT-V transgenic mice (sGnT-V Tg). We found
that the early stage but not mid and late stage wound healing was delayed in sGnT-V Tg mouse
skin. Inflammation is a feature of early stage wound healing. As a result from delayed wound heal-
ing, mRNA expressions of proinflammatory cytokines such as TNFα, IL-6, and IL-1βwere decreased
on day 2 wound skin in sGnT-V Tg mice. Recently it is reported that M1 macrophage plays a role
in the early stage of inflammation and M2 macrophage is important in mid to late stage tissue pro-
liferation during wound healing. The expression of arginase I, the marker of M2 macrophage were
increased on day2 wound skin and the ratio of (arginase I positive macrophage / total macrophage)
were higher in normal skin and day2 wound skin in sGnT-V mice. These results suggest that decrease
in early stage wound healing might be the result of dominant M2 macrophage in sGnT-V Tg mouse
skin. Increased M2 macrophage might also contribute to tumor expansion in the tumor-microenvi-
ronment.
060
Decline of vascular adjustment to pressures in the early stages of aging
J Decorps, D Sigaudo-Roussel and B Fromy FRE CNRS 3310, UCBL1, LYON, France
In healthy skin, local application of low pressures induces a protective pressure-induced vasodila-
tion (PIV) that is lost in advanced aging. When PIV is absent, skin blood flow directly decreases
under low pressures, leading to an early ischemia. Aging is associated with high risk of pressure
ulcers (PU) that partly depends on the intrinsic skin properties to withstand mechanical stress, includ-
ing vascular capacities. Our aim was to test the vascular capacities of the skin to adapt against low
and high pressures in the early stages of aging (12-month mature rats compared to 6-month young
Wistar rats). Using laser Doppler flowmetry, we measured skin blood flow in response to low pres-
sures applied at 11.1 Pa/s (PIV) and the post-ischemic reactive hyperemia following a 3-min appli-
cation of 28.8 kPa. Since PIV requires an intact endothelial function, we also evaluated the endothe-
lium-dependent and –independent responses to acetylcholine (Ach) and to sodium nitroprusside
(SNP), respectively. PIV was reduced in mature rats compared to young rats, indicating a defective
ability to resist to very low pressures. As a consequence, the statistical decrease in skin blood flow
was observed for local pressure as low as 2.3 kPa for mature rats, whereas it occurred at 6.3 kPa for
young rats. At higher pressures, the post-ischemic reactive hyperemia was also reduced in mature
rats compared to young rats, indicating a defective ability of the blood vessels to resume and main-
tain blood flow when the cause of ischemia is removed. These vascular alterations to pressures
were associated with a reduced vasodilation to Ach without changes in vasodilation to SNP, indi-
cating an endothelial dysfunction. In conclusion, the vascular adjustments of the skin to low and
high pressures decline in the early stages of aging. It would be interesting to study how this age-
related decline of the microvascular adjustments to pressures could participate to the increased PU
incidence largely reported in elderly people.
062
Lactobacillus Rhamnosus GG increases the re-epithelialization rate of model wounds by stim-
ulating keratinocyte migration
W Mohammedsaeed,1 C O’Nil,2 A .McBain3 and S Cruickshank4 1 University of Manchester,
Manchester, United Kingdom, 2 University of Manchester, Manchester, United Kingdom, 3
University of Manchester, Manchester, United Kingdom and 4 University of Manchester,
Manchester, United Kingdom
Many studies have demonstrated the importance of probiotics and their potential therapeutic effects
within the gut (Maria, 2008).Recently, the possible therapeutic effects of probiotics in other tissues
has also begun to be investigated. Comparatively few studies have evaluated the use of topical pro-
biotics in relation to the skin. In this study, we have conducted preliminary investigations into whether
a well known probiotic, Lactobacillus Rhamnosus GG (LGG), can increase the rate of re-epithe-
lialization in a model wound. Primary human keratinocytes (NHEK) were grown in proprietary
medium until confluent. A scratch was then made in the monolayer using a sterile 1000-μl-pipet
tip. The rate of re-epithelialization of the scratch was compared in untreated monolayers and mono-
layers treated with and LGG lysate made using108CFU/ml bacterial cells. The LGG lysate signifi-
cantly accelerated re-epithelialisation of the scratches such that by 18 and 24hours, 92±1.6% and
97±1.5% respectively (P=0.02, n=3) of the scratch area was re-epithelialized compared with 71±1.1%
and 81±1.3% respectively in control monolayers. In vitro proliferation and migration assays using
MTT assay and Trans-well migration assay respectively demonstrated that LGG lysate significantly
increased NHEK proliferation and migration rates relative to controls. However, the dominant mech-
anism was migration because scratches in cell cultures treated with the inhibitor of proliferation,
mitomycin C still re-epithelialized significantly faster in the presence of the LGG lysate than con-
trols (p=0.02). These data demonstrate that lysates from Lactobacillus Rhamnosus GG increase re-
epithelialization by stimulation of keratinocyte migration.The use of probiotic lysates potentially
offers new options to develop treatments that could improve wound healing.
061
Microcirculatory and clinical effects of a new Evodia rutaecarpa fruit extract after topical
treatment of human skin
P Portes, V Bardin, V Charton, G Passaro, E Peyrot, F Durousset, S Lopis-Presle and F Demarne
R&D, Gattefosse SAS, Saint Priest, France
The aim of this study was first, to modulate the human skin microcirculation with a new plant extract
and then, to measure the possible benefits on skin condition, in vivo. Recorded to the Chinese
Pharmacopoeia, Evodia rutaecarpa (Rutaceae) is a fast-growing shrub of Asian origin. Its fruit is
known to hold small amounts of indolequinazoline and quinolone alkaloids. Among them, rutae-
carpine and evodiamine seems interesting for their vasorelaxant properties, described after oral
intake. Nitric Oxide (NO) is the most important factor involved in the endothelial regulation of vas-
cular function. Using DAF-FM specific probe, we measured a significant extracellular NO release
by human dermal microvascular endothelial cells, after a 24h treatment with the Evodia rutaecarpa
fruit extract tested at 1% (+ 169.2%, p=0.01). Blood vessels relaxation was then studied on human
skin explants, after a 24h topical treatment with the plant extract formulated at 1%. After histolog-
ical preparation, microscopy coupled to digital image analysis revealed a statistically significant
increase of the vessels lumen diameter, in papillary and upper part of reticular dermis. This vasodi-
lation was measured either in basal conditions (+ 275%, p=0.0002) or after preliminary noradren-
alin-induced vasoconstriction (+ 252%, p=0.004). These results illustrated the expected effect of
NO on smooth muscle vascular cells. Finally, in a monocentric, randomized, double-blind, der-
matologically-controlled clinical trial, the extract formulated at 3% has been compared to its placebo,
after twice daily application for 28 days. High resolution Laser Doppler blood perfusion Imager
evidenced the increased blood flow (+11.5%, p=0.02) on the cheekbones. Skin texture fineness,
brightness and complexion enhancement were also clinically assessed. To our knowledge, that the
first time that the use of an Evodia rutarcarpa fruit extract is reported for its efficacy on skin micro-
circulation and consequently on skin condition
059
MALDI mass spectrometry imaging reveals a significantly altered proteome during wound-
induced scar formation
TJ Shaw, I Tariq, A Mitchell, HL Byers and GR Coulton Division of Biomedical Sciences, St.
George’s, University of London, London, United Kingdom
Scar formation is the inevitable and currently untreatable consequence of tissue damage, and mis-
regulation can lead to the development of pathological scarring such as keloids. In developed coun-
tries alone, it is estimated that ~100 million people each year will be left with a scar following sur-
gery; moreover, there are ~ 11 million people with keloid scars. Despite the high incidence and
debilitating nature of both normal and keloid scars, we still lack effective treatments. The lack of
understanding about exactly which molecules are contributing to, or are responsible for, scar for-
mation is impeding progress in developing targeted therapeutics for their treatment. This project
used MALDI Mass Spectrometry Imaging to identify a signature of proteins expressed during scar
formation. Scars resulting from excisional skin wounds made to the dorsal skin of adult male mice
were collected at 7 or 14 days post wounding, freshly frozen, cryosectioned, coated with matrix
optimised for the detection of proteins in the 2-20kDa range, and irradiated with a nitrogen laser
beam at 80 micron intervals across the tissue sections. The resulting mass spectra revealed a sig-
nificantly and reproducibly altered proteomic signature in scarred versus normal dermis. Specifi-
cally, proteins having mass-to-charge values (m/z; ~equivalent to mass in Daltons) of ~2797, ~4743,
~6284 and ~6657 were expressed at higher intensities in scar vs normal tissue on Day 7, and the
up-regulation of 3 had resolved by Day 14. Peaks at m/z ~4970 and ~6284 showed a significant
up-regulation in scar tissue on Day 14 post wounding. On-going work is focused on: 1) identifica-
tion of the protein(s) represented by the differentially-expressed peaks; 2) using MALDI imaging
and our established “scar signature” to evaluate the anti-fibrotic potential of novel therapies, and;
3) comparison of the “scar signature” observed in skin to other fibrotic tissues. The results of this
work are hoped ultimately to be of prognostic, diagnostic, or therapeutic value.
063
Transcriptome profiling in a delayed wound healing skin-humanized mouse model revealed
genes implicated in extracellular matrix remodeling and collagen deposition
L Martínez-Santamaría,1 C Conti,2 F García-García,3 S Llames,4 L Retamosa,1 A Holguín,1
N Illera,1 J Dopazo,3 M Del Río1 and M Escámez1 1 Regenerative Medicine Unit, CIEMAT and
Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER) U714
Department of Bioengineering, Universidad Carlos III, Madrid, Spain, 2 Department of
Molecular and Cellular Medicine, College of Medicine, Texas A&M Health Science Center
TAMHSC, College Station, TX, 3 Department of Bioinformatics, CIPF and Centro de
Investigación Biomédica en Red en Enfermedades Raras (CIBERER) U715 Functional
Genomics Node, National Institute of Bioinformatics, Valencia, Spain and 4 Tissue Engineering
Unit, Centro Comunitario de Sangre y Tejidos de Asturias (CCST) and Centro de Investigación
Biomédica en Red en Enfermedades Raras (CIBERER) U714, Oviedo, Spain
Chronic ulcers management remains a major clinical challenge since pathogenic mechanisms
responsible for healing impairment are not fully understood. Alterations in the granulation tissue
formation appeared as a major cause of the delayed closure in a diabetes-induced delayed human-
ized wound healing model recently established in our laboratory. Furthermore, the treatment of such
diabetic wounds with bioengineered dermis improved the healing response by triggering granula-
tion tissue maturation. Aiming to dissect the molecular mechanisms responsible for the delayed
healing in the model, global gene expression studies rendered a total of 49 differentially regulated
transcripts. Most of them were related to extracellular matrix remodeling and collagen deposition,
as revealed by functional enrichment analysis. Remarkably, microarray data supported granulation
tissue alterations observed in the humanized diabetic wound healing model that were in turn, res-
cued after bioengineered dermis treatment. In conclusion, our data may shed light on the mecha-
nisms involved in wound healing impairment. Therefore, these findings may have a relevant impact
in the design of innovative therapeutic approaches for the treatment of diabetic wounds that could
also be extended to the management of hard-to-heal wounds of other etiologies
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Serum and Tissue Angiotensin-Converting Enzyme Activities in Psoriasis
D Rhee, C Won, S Chang, M Lee, J Choi and K Moon Dermatology, Asan Medical Center, Seoul,
Republic of Korea
Complete renin-angiotensin system is present in the human skin and angiotensin-converting enzyme
(ACE) was identified in the human keratinocytes. Angiotensin II (Ang II), a product of ACE action, is
found to have a role as a proinflammatory molecule. In addition, Ang II is known to stimulate ker-
atinocyte migration by epidermal growth factor (EGF) receptor transactivation through the shed-
ding of heparin-binding EGF-like growth factor. In this study, serum ACE was measured in 30 pso-
riasis patients. According to clinical symptoms and history including sex, age, onset, duration and
psoriasis area severity index (PASI) scores, all of the data were separately analyzed. And we also
have examined tissue ACE and Ang II receptors (AT1R, AT2R) of the psoriatic lesional skin (n=13),
psoriatic non-lesional skin (n=13) and normal skin (n=5) by the immunohistochemical stain, west-
ern blot, reverse transcriptase-polymerase chain reaction and high performance liquid chromatog-
raphy (HPLC). In results, serum ACE was strongly correlated with PASI score. Overexpression of tis-
sue ACE, AT1R and AT2R were found in the psoriatic skin lesions compared to the normal and
psoriatic non-lesional skin. We suggest that ACE is probably related to the pathogenesis and sever-
ity of psoriasis.
065
Effects of high glucose on human keratinocytes and the beneficial effect of KdPT against glu-
cotoxicity
P Gkogkolou,1 M Sarna,2 TA Luger1 and M Böhm1 1 Department of Dermatology, University of
Münster, Münster, Germany and 2 Department of Medical of Physics and Biophysics, AGH
University of Science and Technology, Cracow, Poland
Foot ulcers are a major complication in diabetes and their treatment remains until today a clinical
challenge. In this work, we investigated the effects of high glucose on normal human keratinocytes
(NHK), a key cell type in cutaneous wound healing. Moreover we tested the potential of KdPT, an
alpha-MSH-derivative with cytoprotective properties, against glucotoxicity. Hyperglycemic condi-
tions (10-30 mM) time- and dose-dependently reduced metabolic activity, proliferation, viability
and migration of NHK. These effects correlated with profound changes in cellular morphology and
biomechanical properties, as shown by atomic force microscopy. In contrast to other cell types
exposed to high glucose, no apoptotic or autophagic pathways were induced. Mechanistically, high
glucose increased intracellular oxidative stress and induced expression of glucose-regulated-pro-
tein-78, a marker of endoplasmic reticulum stress. KdPT exhibited significant protective effects
against glucotoxicity in read-outs of cell migration, metabolic activity and viability. Moreover,
KdPT significantly reduced high glucose-induced intracellular oxidative stress. Our next goal is to
validate these in vitro generated data in an ex vivo wound healing model, which could be further
used as a preclinical screening tool for potential therapeutic candidates. In summary, our data cre-
ate a basis for better understanding the mechanisms of impaired wound healing in diabetes and pos-
sibly point towards novel therapies for diabetic foot ulcers.
066
Immunohistochemical study of dermal microvasculature density and vessel basement mem-
brane thickness in Bateman’s senile purpura
RG Borroni,1 S Grassi,2 M Concardi,3 I Puccio3 and E Arbustini3 1 Molecular Diagnostics
Laboratory, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, 2 Dermatology, Fondazione
IRCCS Policlinico San Matteo, Pavia, Italy and 3 Centre for Inherited Cardiovascular Diseases,
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Bateman’s senile purpura (SP) is a common condition, characterized by non-inflammatory pur-
puric patches on photoaged skin after minor trauma, not associated with coagulation defects or
corticosteroid therapy. We studied the role of microvasculature in SP. Four-mm punch biopsies
were obtained from extensor forearm of patients with SP (mean age 75.4 years), both from skin
lesions within 5 days since onset (n=8) and from non-lesional photoaged skin (n=5). Healthy exten-
sor forearm skin biopsies from young subjects were used as controls (n=5; mean age 30.2 years).
In an area within 500 μm of the dermoepidermal junction the number of vessels per mm2 and
microvasculature basement membrane thickness were assessed by immunohistochemical expres-
sion of CD31 and collagen IV, respectively. Computer-assisted quantitative morphometric analysis
was performed on 3 different fields of each section at ×20 magnification in a blind way. The 2-sided
unpaired t-test was used to analyze differences in microvessel density and basement membrane
thickness. Histologically our results show that despite massive extravasation of erythrocytes there
was no evidence of blood vessel rupture in SP. In addition, microvasculature density was not sig-
nificantly different between SP and non-lesional photoaged skin. Both SP lesions and non-lesional
photoaged skin showed significantly reduced microvasculature density compared to healthy young
skin (p <0.05 and p <0.01, respectively). The average thickness of microvasculature basement
membrane was significantly increased in SP compared to both non-lesional photoaged skin and
healthy young skin (p <0.01). Our data suggest that vessel fragility alone may not explain the
occurrence of SP. Deposition of collagen IV in vessel basement membrane may underlie functional
abnormalities of vessel wall in SP.
067
Phenotypic and functional study of age-related changes in primary dermal fibroblasts
C Brun,1 F Jean-Louis,1 T Oddos,2 A Bensussan1 and L Michel1 1 U976, INSERM, Paris, France
and 2 Research Center, Johnson & Johnson Santé Beauté France, Val de Reuil, France
Cutaneous wound healing requires dermal fibroblasts to be recruited at the lesion site, where they
proliferate, differentiate into myofibroblasts under local cytokine activation and synthesize extra-
cellular matrix (ECM). Skin aging is characterized by defects of skin wound healing, leading to
chronic wounds and ulcers or cutaneous fibrosis. The aim of our study was to characterize molec-
ular and functional alteration of fibroblasts obtained from “aged” donors (>45 years) and to com-
pare them to fibroblasts from young donors (<45 years). Short-term dermal fibroblast cultures were
established using skin from mammary plastic surgery of young donors (n=6) and aged donors
(n=6). The senescent status was evaluated by detection of “senescence associated β-galactosidase”
(SA-βgal) activity. The expression of senescence markers (p16, p21, p53) was analyzed by quanti-
tative PCR and western blot. ECM production and degradation, contractile and migratory capaci-
ties as well as fibroblast differentiation into myofibroblasts under TGFβ activation (α-smooth mus-
cle actin [αSMA] expression) were also assessed. SA-βgal activity confirmed the senescent status of
fibroblasts from aged donors compared with fibroblasts from young donors, with 31.2±18% and
61.9±16% of SA-βgal-positive cells, respectively (p<0.005). Senescence marker expression was cor-
related to SA-βgal activity and significantly increased with age. In particular a 65% fold increase in
p16 expression was detected in aged donors compared with the younger counterparts (p<0.01).
The ability of fibroblasts to differentiate into myofibroblasts decreased with age, as shown by lower
expression of αSMA after TGFβ stimulation, lower TGFβ production and loss of proliferative and
contractile capacities. In conclusion, the phenotypic and functional differences we observed between
fibroblasts from young and aged donors could contribute to the alteration of wound healing process
during cutaneous aging.
068
Plantaricin A accelerates wound healing by modulating the gene expression of TGF-β1, FGF7,
VEGF-A and IL-8 in human keratinocytes
B Marzani,1 D Pinto,1 M De Angelis,2 M Gobbetti,2 A Benedusi1 and G Giuliani1 1 R&D, Giuliani,
Milan, Italy and 2 Department of Biologia e Chimica Agro-Forestale ed Ambientale, University
of Bari, Bari, Italy
Plantaricin A (PlnA) is a 26-residue bacteria-produced peptide pheromone with membrane-per-
meabilizing antimicrobial activity. PlnA was chemically synthesized and used as pure peptide or
biologically synthesized during co-cultivation of Lactobacillus plantarum DC400 and Lactobacil-
lus sanfranciscensis DPPMA174. The cell-free supernatant (CFS) was used as the crude preparation
containing PlnA. The inductive effect of PlnA on the proliferation of NCTC 2544 cells was higher
than that found for hyaluronic acid, a well known skin protective compound. As shown by scratch
assay and image analyses, PlnA enhanced the migration of NCTC 2544 cells. Compared to the basal
serum free medium (control), the highest inductive effect was found using 10μg/ml of chemically
synthesized PlnA. Similar results (P>0.05) were found for CFS. In agreement, the percentage of the
starting scratch area was decreased after treatment (24h) with PlnA. The expression of transforming
growth factor-β1 (TGF-β1), keratinocyte growth factor 7 (FGF7), vascular endothelial growth factor
(VEGF-A), and interleukin-8 (IL-8) genes was affected by PlnA. Compared to control, TGF-β1 gene
was under expressed in the first 4h of treatments and up-regulated after 8-24h. On the contrary,
FGF7 gene was strongly up-regulated in the first 4h of treatments. Compared to control, VEGF-A
and IL-8 genes were always up-regulated during the 4-24h from scratching. Since capable of pro-
moting the proliferation and migration of the human keratinocytes and of stimulating IL-8 cytokine,
the use of PlnA for dermatological purposes should be considered.
069
Expression of neuroserpin, a serine-protease inhibitor, in the human skin
J Chéret, N Lebonvallet, L Misery and C Le Gall-Ianotto Laboratory of Neurosciences of Brest
(EA4685), University of Western Brittany, Brest, France
Since several years, it has been becoming clear that serine proteases and their specific inhibitors,
the serine protease inhibitors (SERPINs) are implicated in a number of physiological and patholog-
ical events in the skin. In particular, the fibrinolytic system and its most known inhibitor, the plas-
minogen activator inhibitor-1 (PAI-1) are known to be involved in physiological and pathological
wound healing, as in the pathogenesis of skin fibrosis or in invasion and metastatic spread of
melanoma cells. Neuroserpin (NSP), a member of the SERPIN superfamily, could be able to inhibit
this system. Its expression, initially described in the central nervous system, was also detected in
different organs such as pancreas, heart, kidney and testis but was never investigated in the human
skin. We analyzed neuroserpin expression in 10 human skin samples (HSS). The mRNA of NSP was
detected by RT-PCR in all HSS and the expression of the protein could be detected by Western blot
in all HSS. The expression of NSP in skin was confirmed by immunohistochemistry and found to be
only present in the dermis, essentially around blood vessels. Co-immunostaining with an anti-CD31
allowed to confirm that hNSP was exclusively expressed in dermal endothelial cells. As PAI-1, NSP
may have a role in various physiological and/or pathophysiological mechanisms in human skin but
this remains to be determined.
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Haemoglobin Distribution in Ulcers for Healing Assessment
A Fadzil,1 L Ahmed,1 A Malik,1 A Jamil2 and F B. Bin3 1 Centre for Intelligent Signal & Imaging
Research, Universiti Teknologi Petronas, Tronoh, Malaysia, 2 Department Of Medicine,
Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia and 3 Department
of Dermatology, General Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
Non-healing chronic wounds often develop into ulcers that put patients at risk of limb amputation.
For wound management efficacy, it is crucial to measure early therapeutic response objectively. An
early indication of wound healing is the growth of granulation tissue, which appears red in colour
due to haemoglobin content in the blood capillaries formed during healing. This work focuses on
investigating haemoglobin content in colour images of ulcers as an image marker to detect the newly
growing granulation tissue. Data transformation using independent component analysis is applied
on thirty ulcer colour images to extract grey-level images of haemoglobin distribution reflecting
regions of granulation tissue. Clustering based segmentation utilizing fuzzy c-means is applied to
segment regions of granulation tissue from the extracted haemoglobin images. The algorithm per-
formance is compared with dermatologists’ manual tracings of granulation tissue on the ulcer images.
The developed algorithm performs fairly well in detecting regions of granulation tissue with an aver-
age sensitivity of 83.12% and specificity of 88.05%. Most ulcers contain granulation tissue that can-
not be discerned visually as it is scattered over the surface with other tissues especially slough. Der-
matologists either perceive these regions as granulation which results in low sensitivity (more false
negatives) or as slough which results in low specificity (more false positives) when comparing algo-
rithm performance with dermatologists’ assessment. The algorithm is capable of detecting regions
of granulation tissue that indicate early healing capability and cannot be discerned visually. The
area of the detected granulation regions can be measured and used as an objective non-invasive
measure to evaluate the healing status of chronic ulcers.
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